NHS Dudley Health Economy Medicines Formulary
Home > 8 Malignant disease and immunosuppression > 8.1 Cytotoxic drugs > 8.1.5 Other antineoplastic drugs > Nivolumab for treating advanced (unresectable or metastatic) melanoma - NICE TAG TA384

Nivolumab for treating advanced (unresectable or metastatic) melanoma - NICE TAG TA384

1.1 Nivolumab as monotherapy is recommended, within its marketing authorisation, as an option for treating advanced (unresectable or metastatic) melanoma in adults.

https://www.nice.org.uk/guidance/ta384 

Site by Devopa
© Copyright 2019 NHS. All rights reserved.